Inactive Instrument

Onyx Pharmaceuticals, Inc. Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

27/13/27	Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen	RE
26/13/26	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE

27/13/27	Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen	RE
26/13/26	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE
26/13/26	Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost	RE
26/13/26	AstraZeneca plc : AstraZeneca to buy U.S. cancer firm for up to $500 million	RE
25/13/25	Pfizer Limited : Amgen close to buying Onyx for $125 per share: sources	RE
22/13/22	Amgen, Inc. : Exclusive: Onyx provides drug trial data to potential bidders - sources	RE
16/13/16	Onyx Pharmaceuticals, Inc. : Amgen seeks drug trial data before finalizing Onyx deal: sources	RE
08/13/08	Bank of America Corp : Amgen deal for Onyx possible within week - sources	RE
08/13/08	Bank of America Corp : Amgen deal for Onyx possible within week-sources	RE
19/13/19	Biogen Idec Inc : Exclusive: Pfizer not moving forward with Onyx bid: sources	RE
17/13/17	Ranbaxy Laboratories Limited : Novartis lifts full-year outlook after competition delay	RE
13/13/13	Pfizer Inc. : Roche seeks financing for potential Alexion bid -sources	RE
02/13/02	Insmed Incorporated : S&P 500 extends gains to year's second half on solid data	RE

01/15/01	Onyx Pharmaceuticals : Amgen Receives CHMP Positive Opinions for Two New Treatment Options for Patients with Blood Cancer in Europe	PU
23/15/23	Onyx Pharmaceuticals : Amgen Submits Supplemental New Drug Application for Kyprolis® (Carflizomib) in Relapsed Multiple Myeloma	PU
31/15/31	Onyx Pharmaceuticals : Amgen Initiates Phase 3 Study Evaluating Once-Weekly Kyprolis® (Carflizomib) in Patients with Relapsed and Refractory Multiple Myeloma	PU
28/15/28	Onyx Pharmaceuticals : Amgen to Advance Understanding of the Treatment of Blood Cancers at the 20th Congress of European Hematology Association (EHA)	PU
14/15/14	Onyx Pharmaceuticals : Amgen Data at ASCO 2015 Highlight Oncology Pipeline and Portfolio	PU

27/13/27	Onyx Pharmaceuticals, Inc. : Les propos de Kerry sur la Syrie font trébucher Wall St
26/13/26	Wall Street ouvre sans grand changement
26/13/26	Les valeurs à suivre aujourd'hui à Wall Street
26/13/26	USA-Les valeurs à suivre à Wall Street (actualisé)
26/13/26	Amgen, Inc. : s'offre le groupe pharmaceutique ONYX pour 10,4 milliards de dollars

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-1.59%	-3.35%	+64.49%	+98.69%	6.95TCr
ARGENX SE	-1.34%	-0.75%	+48.56%	+90.63%	6.5TCr
BIONTECH SE	-8.37%	-12.43%	+0.14%	-15.42%	2.56TCr
INSMED INCORPORATED	-2.35%	-5.75%	-12.17%	+448.29%	2.59TCr
WUXI BIOLOGICS (CAYMAN) INC.	+0.30%	-0.69%	+63.18%	+11.93%	2.65TCr
PHARMAESSENTIA CORPORATION	-0.96%	+10.36%	+278.86%	+438.78%	2.02TCr
GENMAB A/S	-0.51%	+0.23%	+33.71%	-18.02%	2TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-1.91%	-4.37%	+13.33%	+531.29%	1.57TCr
EXELIXIS, INC.	-1.47%	+0.68%	+43.67%	+145.49%	1.35TCr
Average	-2.02%	-1.93%	+59.31%	+192.41%	3.13TCr
Weighted average by Cap.	-1.93%	-1.50%	+57.15%	+152.82%

Employees

Sector